Generic Drug Review: US FDA Approves More ANDAs Than It Receives For First Time Since Early 2016
Among the 61 approvals in February appear to be ANDAs from the official GDUFA backlog, which have been pending for more than four years.
Among the 61 approvals in February appear to be ANDAs from the official GDUFA backlog, which have been pending for more than four years.